Abstract-A useful correlation between maximum thyroid uptake and radioiodine urine levels at different times after exposure was developed in order to determine when the intervention with an adequate blocking agent might still be effective. In an animal model (dog), six different doses were administered in the range of 100-600 kBq. The best correlation was found between the "' I uptake after 48 h (T-48) and urine radioactivity 4-6 b (U-4, U-5, U-6) after exposure. The validity of this correlation was confirmed in four volunteers who received small doses of "' I (25-100 kBq), with good agreement between measured and extrapolated thyroid uptake and a mean difference of less than 10% (CV = 16.2%). Three different blocking agents were then tested in the same dog: potassium iodide, potassium perchlorate, and a thionamide (TapazoleTM). The blocking action of the first two compounds was about 90%, as opposed to only 48% for the third compound. Potassium iodide was chosen for its limited side effects and more universal utilization. The final study, carried out with four different doses, indicated that 25 mg of KI is the ideal amount to be administered to the dog. This corresponds to approximately 100 mg for a 70 kg human being (i.e., 1.4 mg kg-'). This dose, when administered to a volunteer 4 h after exposure, provided a thyroid blocking of 68%. Health Pbys. 76(1):11-16; 1999
INTRODUCTION
THE AUGER electron emitter 1251 has been found to exhibit substantial toxicity to mammalian cells (Persson 1994; Hofer and Bao 1995) . In addition to its classical applications in antigen and antibody labelling for immunoassay and receptor studies (Thorpe and Rafferty 1994; Rudick 1994) , this radioisotope shows increasing promise in dfferent approaches to cancer diagnosis and therapy (Bender et al. 1992 ; Kassis et al. 1993; Harrison et al. 1994; Critz et al. 1995; Femandez et al. 1995; Daghighian et al. 1996) .
Depending on their subcellular distribution, the biological effects caused by cell-incorporated Auger emitters can be as severe as those of high-linear energy transfer (LET) alpha particles (Persson 1994) . With the potential increased use of high activities of this radioisotope, it is important to minimize exposure and increase the control of personnel involved in its manipulation (Kivinitty et al. 1984; Bartolini et al. 1988; Zvonova and Shalatenko 1994) , as well as that of the patients being treated. In this respect, it is important to recall three incidents that occurred at the Medical College of Virginia, involving the release of lZ5I from seeds implanted withm the prostate gland, which motivated the recommendation of a prompt use of urinalysis (Broga and Gilbert 1983) .
In the present investigation, we studied the possibility of blocking thyroid incorporation of radioiodine during the first few hours after exposure utilizing radioiodine urinalysis to predict when potentially large thyroid uptakes might occur (Broga et al. 1986) . In this manner, a suitable blocking agent could be administered only when needed, greatly diminishing the toxicity risks due to repeated prophylactic use (Adams and Bonnel 1962; Blum and Eisenbud 1967; Ellis et al. 1977; Wootton and Hammond 1978; Meck et al. 1985; Martin 1985; Crocker 1984; Moody et al. 1988; Malone et al. 1991) . The study was carried out in an animal model (dog) and in human subjects, using 1251 and 1311, with special emphasis on the former radioisotope. Most of the conclusions of the study for lZ5I are also valid for 13'1, a radioisotope widely used in radiodiagnosis and therapy (Fritzberg et al. 1988; Weadock et al. 1989; Clerc et al. 1995) and sometimes handled at very high activities (e.g. 515 mCi or 19 GBq) in the treatment of metastatic thyroid cancer (Rudavsky and Freeman 1997) .
MATERIALS AND METHODS

Animal model
A male random-bred dog weighing 16 kg and whose neck was approximately human size was used for all the experiments. Its clinical condition was evaluated before starting the study and found to be normal in general and with respect to thyroid function. The animal was housed in a metabolic cage to facilitate urine collection. Water and a commercial canine diet (Nuvita, Siio Paulo, Brazil) were provided ad libitum. Since the rate of thyroidal iodine turnover is much higher in the dog than in humans and the net thyroidal uptake of iodide per day is 5 times greater, the diet used for the animal was supplemented with KI, up to 1 mg iodine per kg, in agreement with literature data (Belshaw et al. 1974) .
Six different doses (see "Results") of Na'251, the absolute radioactivity determined as previously reported (Bartolini et al. 1988) , were injected into meat and administered orally to the dog. In each case the bladder had just been emptied. Thyroid monitoring was carried out, as previously described (Bartolini et al. 1988) , for timed periods of 10 min every hour during the first 10 h, and then at 24, 48, and 72 h after 1251 administration. Urine was also collected every hour during the first 10 h; 3-mL aliquots were counted for 1 min in a well-type gamma counter.* The results were expressed on the basis of the total volume. Maximum thyroid uptake (indicated as T-48) and the activities found in urine at different times (U-1 to U-10) were correlated considering the individual and integrated urinary outputs. The integrated output for a given time was obtained in a cumulative way by summing the values obtained for the previously collected samples.
Three different blocking agents, i.e., potassium iodide, § potassium perchlorate," and a thionamide (Tapazole ¶), whose doses are specified in "Results," were also given to the dog 4 h after administration of a given "'I activity. Thyroid measurements were carried out every hour during the first 10 h, and then 24, 48, and 72 h post-administration. The data were then compared with control experiments carried out without the use of a blocking agent. Since the same animal was always used, a sufficient time interval was allowed to elapse between any two subsequent experiments in order to reduce thyroid counts to background level.
Human studies
The correlation between 24-h thyroid uptake (T-24) and urinary 1311 output was also determined in humans in collaboration with the Cancer Institute "Amaldo Vieira de Carvalho" (Siio Paulo, Brazil). Data for n = 20 normal individuals of both sexes, aged 20-50 y, were obtained from volunteers or patients submitted to the 24-h uptake procedure for the assessment of thyroid function (only patients found to be normal were used in this study). For some patients (n = 16), it was also possible to determine the 2-h urinary output (U-2). Four additional volunteers who received small doses of lZ5I (20-100 kBq) were ' similarly studied in the laboratory of IPEN-CNEN/SP and used to validate the derived correlation. One of these volunteers also received a bloclung dose of 1.4 mg KI * Cobra auto-gamma, Packard Instruments, Downers Grove, IL. kg-' 4 h after Na lZ5I administration. All 13'1 thyroid measurements were carried out on a XL-1502 counter.' Fig. 1 illustrates the thyroid uptake of the dog following six different administrations of lZ5I. To test the reproducibility of the animal response one of the dose levels (254 kl3q) was repeated after about 1 y (263 kl3q). In all experiments, the largest thyroid uptake was detected 48 h after ingestion. Total administered lZ5I, integrated urinary output, and 48-h thyroid uptakes (T-48) for each experiment are reported in Table 1 . Statistical analysis was carried out by determining the ' Philips, Eindhoven, Netherlands. correlation between the cumulative urinary lZ5I outputs for each time and T-48. These data show that the correlation coefficient (r) clearly improves with longer urine collection time, as does its significance. Since the highest level of significance was effectively reached after 4 h, this post-exposure time was chosen as the most suitable for urine collection. In the same table, it can be seen that there is a highly significant correlation between ingested activity and T-48. We can also observe the percentages of lZ5I uptake 48 h after administration, the average value being 6.8% for the six experiments. The correlation between 48-h thyroid uptake and 4-h urinary output is illustrated in Fig. 2 , where the corresponding equation is also reported.
RESULTS
Concerning the study in humans, Table 2 reports the doses of 1311 administered to a normal population and the percent thyroid uptakes for 2, 4, and 24 h. Fig. 3a presents a plot of the 4-h urinary output against the 24-h thyroid uptake for the same population. Considering that we were mainly interested in Iz5I applications, all 1311 activity values were normalized to those which would be provided by the same number of atoms of lZ5I. This permits the two studies, on a dog and on humans, to be more easily compared. From the equations presented in Fig. 2 and Fig. 3a it can be seen that the correlation coefficients and significance levels are practically identical in the two studies, but with a 47% higher slope of the curve in the case of human beings. The limit of acceptability of 13 kI3q for the 4-h urinary output is indicated by an arrow in Fig. 3a . This value is derived from the lZ5I thyroid burden of 18.5 kl3q (0.5 pCi), which determines action point N.2 for which medical consultation is recommended (US. NRC 1979 ). An analogous analysis in which T-24 was correlated with U-2 instead of U-4 is presented in Fig. 3b . Since the equation presented in Fig. 3a provided the better correlation, it was therefore used to ate, and 100 mg of potassium iodide were iven to the dog 4 h after the ingestion of 250 kBq of 12' L The dose of each blocking agent was chosen on the basis of general clinical use. Fig. 4 shows that, relative to the two experiments carried out in the absence of blocking agent, potassium iodide and potassium perchlorate blocked, respectively, 90% and 91% of the radioiodine taken up by the thyroid at 48 h. Under the same conditions, Tapazole blocked only 48%. In a separate experiment, four different doses of potassium iodide were given to the dog, again 4 h after ingestion of approximately the same radioactivity (250 kEiq) (Fig. 5) . Relative to nonblocking experiments, a 25-mg dose of KI presented an action practically identical to 100 mg of KI, i.e., 85% vs. 90% blocking. The first dose was therefore chosen as the most suitable for in vivo use in humans. Considering the dog's weight, this corresponds to about 100 mg KI for a 70-kg human being (i.e., 1.4 mg KI kg-I). The reproducibility of the animal response was further confirmed in two experiments carried out 1 y apart, both with 25 mg KI. When the same dose of KI was given to volunteer No. 4 (Table 3) 4 h after the ingestion of 38.1 kl3q of IZ5I, a blocking of 68% was observed after 48 h, relative to the experiment in which no blocking agent was used (Fig. 6) . calculate the activity that would be taken up by the thyroid of 4 volunteers who received small doses of 5I ( Table 3) . The data in this table c o n f m the agreement between calculated and effectively measured 24-h thyroid uptakes for these normal subjects. The analysis of three different thyroid blocking agents was carried out only on the animal. In a first experiment, 5 mg of Tapazole, 1 g of potassium perchlor-
DISCUSSION AND CONCLUSION
The results obtained in this study demonstrate that it is possible to predict major thyroid uptakes in time to carry out effective thyroid blocking when the time of iodine intake is known. The high level of significance of this correlation was first demonstrated in an animal model, a single dog to which different 1251 activities were administered, followed by repeated thyroid and urine measurements. The study was then extended to human subjects to whom, for obvious ethical reasons, no such variety of doses or blocking agents could be administered. It was thus possible to predict via urinalysis, to a good approximation, the radioiodine taken up by the thyroid. The experiment carried out on 4 volunteers whose 24-h thyroid uptakes were then effectively measured represents the best confirmation of the validity of this approach.
The efficacy of three different blocking agents, administered 4 h after ' "1 ingestion, was comparatively tested in the same dog. Potassium iodide and potassium perchlorate were the most effective, while Tapazole presented a slower, more limited action. It shouid be emphasized that, even by intervening only 4 h after exposure, it was still possible to obtain a 90% blocking. This is better than the 80-85% value obtained by Moody et al. (1988) , who treated ten dogs with a topical application of povidone I solution (Betadine**) 2 h before exposure. Approximately the same blocking effect could be observed in the volunteer that received KI 4 h after 1251 administration. The 68% thyroid blocking achieved was consistent with the data obtained after 1311 administration to 20 healthy subjects (Table 2 ). These data indicate that 34% of the maximum uptake had already reached the thyroid 4 h after radioiodine ingestion, with 66% therefore still being subject to blocking. The blocking in the dog turned out to be more effective due to the very small uptake occurring after 4 h (14% of T-24). Our data are in quite good agreement with the few reports in which a tt F'urdue Frederick Company, Nonvalk, CT. blocking agent was experimentally administered some hours after exposure (Blum and Eisenbud 1967; Ramsden et al. 1967; Pahuja et al. 1993) . The blocking in humans might potentially have been even more effective (up to about SO%, according to Table 2 ) using the correlation based on the 2-h urinary output, reported in Fig. 3b . This is in good agreement with experimental and calculated literature values of 69 -84% blocking when KI was administered after 1.5-2 h (Blum and Eisenbud 1967; Ramsden et al. 1967; Ill'in et al. 1972; Meck et al. 1985) . In conclusion, it is possible to predetermine, for a given radioisotope of iodine, a limit of acceptable thyroid burden for which a corresponding 4-h or 2-h urinary limit can be established, as was demonstrated here using the recommendation of the U.S. Nuclear Regulatory Commission. Any time this urinary limit is exceeded, the suitable amount of KI should be given to the exposed workers, who would only be required to void and count a urine sample at a certain time after radioisotopic manipulation or a presumed accident. In this manner, even the deleterious effects due to the repeated use of a blocking agent can be avoided. The limited dose of 1.4 mg KI kg-' body weight was indeed found to provide an efficient blocking action. This agrees well with the literature data mentioned above and with the conclusion of a very recent study carried out in infant chimpanzees, which recommends the use of at least 1.5 mg stable iodide per kilogram for effective thyroid protection (Noteboom et al. 1997) .
